CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- 4 Open-market sale Chief Financial Officer sold 521 shares at $41.51 ($21,627)
- 4 Open-market sale President sold 525 shares at $41.51 ($21,793)
- 4 Open-market sale Chief Executive Officer sold 994 shares at $41.51 ($41,261)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Grant or award Chief Financial Officer acquired 69,230 shares (grant or award)
- 4 Grant or award President acquired 110,770 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 224,620 shares (grant or award)
- 4 Grant or award Director acquired 1,182 shares (grant or award)
- 4 Grant or award Director acquired 1,147 shares (grant or award)
- 4 Grant or award Director acquired 1,828 shares (grant or award)
- 8-K Event Results of operations
- 4 Open-market sale Chief Financial Officer sold 30,452 shares at $14.02 ($426,937)
- 144 Insider Sale of Securities
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
Page 9 of 14 · 267 filings